AI Generated Image
Northwestern study
NewsNation • • health
Key Points:
- A Northwestern University study presented at the Endocrine Society’s annual meeting found that GLP-1 drugs like Ozempic and Wegovy are linked to an increased risk of low blood pressure events, including dizziness and fainting.
- The study analyzed 42,000 adults on at least two blood pressure medications and observed that low blood pressure events rose from 8.7% to 10.2% within six months of starting GLP-1 treatment, with risks remaining elevated after 12 months.
- Older adults (65+) and people with diabetes were identified as the most vulnerable groups to these adverse effects.
- Researchers noted that weight loss alone did not account for the increased risk, indicating other mechanisms may contribute to the low blood pressure events.
- The study’s senior author, Dr. Micah Eimer, emphasized the seriousness of these events and urged clinicians to monitor at-risk patients closely, especially those using GLP-1 drugs without ongoing medical supervision.
